diagnostics | pharmaphorum

Monday 25 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

diagnostics

News

Owlstone's ReCIVA is being developed to diagnose lung cancer, but also has applications in precision medicine trials

Disease breathalyser firm Owlstone appoints 'serial entrepre...

Owlstone Medical, a UK diagnostics company developing a breathalyser for early disease detection, has announced Dr Andy Richards has joined its board.

News

Lungs

Breath Biopsy company adds new investor to $15m fundraising

Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient's breath has been given a major funding boost.

Views & Analysis

iStock 865332628_CoverpicFutureofDiagnistics

The future of diagnostics: personal genetic services

With genetic analysis and diagnostic tests now available via mail order, how will this trend towards the proactive consumer impact the evolution of health management?

News

parsortix2

Angle produces new data backing liquid biopsy in cancer

Angle hopes Parsortix will be first approved cell-based liquid biopsy.

News

breath-biopsy

Major trial for potential 'game changer' cancer diagnostic b...

Breath Biopsy will be tested in its ability to detect several cancers earlier than traditional methods.

News

parsortix2

Angle poised to take on US cancer diagnostics market

Circulating tumour cell test could help select drug therapy.